BioSpace News Archive

The company’s groundbreaking nanotechnology significantly improves performance of Li-Ion batteries used in electric vehicles, drones and energy storage plants

Return Ready™ offers organizations a customizable COVID-19 testing solution, clinical protocols and reporting to meet their unique worksite or campus needs

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that all initial European trial sites are active and enrolling or able to enroll patients into i

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has entered into a co-promotion partnership with Indegene Inc. to establish multichannel digital marketing programs throughout the United States and expand the capabilities for the engagement of health care providers (“HCPs”) who are eli

Biocept, Inc . (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, announces it has entered into a managed care provider agreement with Medical Cost Containment Professionals, LLC (MCCP) to process out

June 24, 2020 12:00 UTC Company’s core technology focused on targeted therapies for autoimmune disease WOBURN, Mass.--( BUSINESS WIRE )-- ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today the dosing of the first patient in a Phase 1 study of IMT-002, an oral small molecule drug designed as a selective HLA-DQ8 blocker for the treatment of type 1 diabetes (T1D). The trial is d

-Immunomic to invest in Replicate’s seed round; funding will enable Replicate to accelerate self-replicating RNA technology and grow operations-

Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix ™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation softwar

-SFA Therapeutics receives award from Ben Franklin Technology Partners- -Melior Discovery selected as partner-

AllerGenis LLC, a data-driven precision diagnostics company focused on food allergies, today announced the onset of operations at its Hatfield facility to test patient samples using its VeriMAP TM Peanut Diagnostic, a diagnostic solution for patients with peanut allergies. AllerGenis received full certification under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform its high complexity clinical l